$6.3M in CY2024 Part D spend590 claims · 96 beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Ado-Trastuzumab Emtansine used for?
Ado-Trastuzumab Emtansine is a this drug class medication tracked in Medicare Part D.
Is there a generic for Ado-Trastuzumab Emtansine?
No. Ado-Trastuzumab Emtansine is brand-only with no generic equivalents currently in market.
How much does my plan pay for Ado-Trastuzumab Emtansine?
NADAC pricing data not currently available for this drug.
Is Ado-Trastuzumab Emtansine on the FDA shortage list?
No. Ado-Trastuzumab Emtansine is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.